当前文献中Gleason评分分组方式的调查分析
该文通过PubMed检索2016-2017年发表的1576篇前列腺癌相关文献,分析Gleason评分(GS)的分组方式。结果显示全球范围内GS分组仍存在广泛差异,仅少数文章准确分组:病理学期刊比非病理学期刊更常单独区分GS 7(56.9% vs 40.0%,p<0.05)及GS 8与GS 9-10(55.2% vs 34.4%,p=0.001),有病理学家合著的文章也更常采用理想分组。研究呼吁更广泛采用五分组新分级系统。
要点
- 仅少数已发表文章准确分组Gleason评分,全球差异显著。
- 病理学期刊及有病理学家合著的文章更倾向于单独区分GS 7和GS 8与GS 9-10。
- 北美和欧洲研究比亚洲研究更常采用理想分级分组。
核心结论
- 当前文献中Gleason评分分组方式仍存在全球性广泛差异,仅少数文章准确分组。
研究设计与样本
- 通过PubMed检索2016-2017年发表的使用「Gleason」和「prostate」的文章,经排除后纳入1576篇文献进行综述分析。
主要发现
- 病理学期刊比非病理学期刊更常单独区分GS 7(56.9% vs 40.0%,p<0.05)。
- 有病理学家合著的文章比无病理学家合著的文章更常单独区分GS 7(53.2% vs 32.9%,p<0.001)。
- 北美和欧洲研究比亚洲研究更常单独区分GS 7(47.6%和44.1% vs 24.1%,p<0.001)。
- 病理学期刊比非病理学期刊更常将GS 8与GS 9-10分开(55.2% vs 34.4%,p=0.001)。
- 病理学期刊比非病理学期刊更常使用理想分级分组(32.2% vs 15.9%,p<0.001)。
临床怎么用
- 临床研究及报告中应优先采用包含五个分级分组的新前列腺癌分级系统,并单独区分GS 7及GS 8与GS 9-10,以减少错误分组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A new prostate cancer grading system was proposed in 2013 and endorsed by major journals and societies in 2014, in part because of anecdotal evidence that Gleason scores (GSs) were incorrectly combined in the literature. OBJECTIVE: To examine how published studies categorized GSs in current practice. DESIGN, SETTING, AND PARTICIPANTS: A PubMed search was conducted on articles published in 2016-2017 using the search terms "Gleason" and "prostate". This literature review included 1576 articles after exclusions. RESULTS: (1) Separating GS 7: pathology journals were more likely than non-pathology journals to grade GS 7 separately (56.9% vs 40.0%, p<0.05). Articles co-authored by a pathologist separated GS 7 more than those without a pathologist (53.2% vs 32.9%, p<0.001). North American and European studies separated GS 7 more than Asian studies (47.6% and 44.1% vs 24.1%, p<0.001). Clinical articles separated GS 7 more than research articles (43.7% vs 32.9%, p<0.001). (2) Separating GS 8 from GS 9-10: pathology journals separated GS 8 from GS 9-10 more than non-pathology journals (55.2% vs 34.4%, p=0.001). Articles co-authored by a pathologist separated GS 8 from GS 9-10 more often than those without a pathologist (44.9% vs 29.5%, p<0.001). (3) Using grade groups as "ideal" with all other groupings "non-ideal": pathology journals used ideal more than non-pathology journals (32.2% vs 15.9%, p<0.001). Ideal grouping is more likely in articles co-authored by a pathologist than in those without a pathologist (20.6% vs 11.0%, p<0.001). North American and European studies used ideal grouping more than Asian studies (17.6% and 14.0% vs 9.1%, p<0.05). (4) Arranging groupings in decreasing order from ideal to non-ideal: pathology journals were closer to ideal than non-pathology journals (p=0.002). Articles co-authored by a pathologist were classified closer to ideal than those without a pathologist (p<0.001). North American (p<0.001) and European (p=0.02) studies were closer to ideal than Asian studies. CONCLUSIONS: There is still wide variation in how GSs are grouped world-wide. Only a minority of published articles group GSs accurately. PATIENT SUMMARY: In this report, we looked at how GSs were grouped world-wide. We found that only a minority of published articles on prostate cancer were grouping GSs accurately, which could lead to inaccurate results and affect patient care with different prostate cancer grades. Our study calls for more widespread adoption of the new prostate cancer grading system composed of five grade groups to minimize incorrect grouping for future studies.
引用
- Zhou AG, Salles DC, Samarska IV, et al. How Are Gleason Scores Categorized in the Current Literature: An Analysis and Comparison of Articles Published in 2016-2017. Eur Urol. 2018. PMID: 30057131. doi:10.1016/j.eururo.2018.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。